Drug discovery - 1 News from the business & finance department by PhoreMost for the pharma industry

Drug discovery - 1 News from the business & finance department by PhoreMost for the pharma industry

image description

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes

16-Sep-2024 - PhoreMost Ltd. announced it has added USD $12 million to its Series B financing, bringing the total raised to over $50 million. The additional investment was led by Parkwalk Advisors, the largest growth EIS fund manager, with participation from existing investors BGF, Dr Jonathan Milner, Amadeus ...

drug discovery inflammatory diseases investments

These products might interest you

PHERAstar® FSX

PHERAstar® FSX by BMG Labtech

Speed up your screening with 1536 samples in just 27 seconds

Discover the fastest microplate reader for high-throughput applications now

microplate readers
View product
Industrial-scale Centrifugal Partition Chromatography platform

Industrial-scale Centrifugal Partition Chromatography platform by RotaChrom Technologies

Make the purification of your compounds of interests scalable and customizable with CPC instruments

RotaChrom brings high R&D potential, reliability and agility to CRO and CDMO in the pharma industry

chromatography systems
View product
Show all drug discovery
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,240 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now